A phantom approach to interscanner comparability of computed tomographic brain perfusion parameters.

OBJECTIVE: This study aimed to create a phantom, which allows reproducible computed tomography perfusion experiments, and to identify the influence of contrast bolus configuration, scan parameters, and scanner hardware on the calculation of perfusion parameters. METHODS: A discoid perfusion phantom with centrifugally directed flow was constructed. Brain parenchyma was simulated by inert polyoxymethylene spheres. Repeated measurements were performed with variations of the above-mentioned factors, and their effects on perfusion results were analyzed. RESULTS: Calculated flow values measured during experiments were reproducible and showed good correlation with the true flow (R = 0.995, P < 0.01). Tube voltage, injection rate of the contrast agent, the mathematical perfusion algorithm, and the hardware of the scanner hardware had a reproducible influence on calculated perfusion results. CONCLUSIONS: In the long term, perfusion phantoms might be helpful in identifying hardware-specific and protocol-related factors of different computed tomography scanners to improve comparability of different scanners and scanning protocols.

Comparison of different mathematical models of diffusion-weighted prostate MR imaging.

PURPOSE: To evaluate which mathematical model (monoexponential, biexponential, statistical, kurtosis) fits best to the diffusion-weighted signal in prostate magnetic resonance imaging (MRI). MATERIALS AND METHODS: 24 prostate 3-T MRI examinations of young volunteers (YV, n=8), patients with biopsy proven prostate cancer (PC, n=8) and an aged matched control group (AC, n=8) were included. Diffusion-weighted imaging was performed using 11 b-values ranging from 0 to 800 s/mm(2). RESULTS: Monoexponential apparent diffusion coefficient (ADC) values were significantly (P<.001) lower in the peripheral (PZ) zone (1.18±0.16 mm(2)/s) and the central (CZ) zone (0.73±0.13 mm(2)/s) of YV compared to AC (PZ 1.92±0.17 mm(2)/s; CZ 1.35±0.21 mm(2)/s). In PC ADC(mono) values (0.61±0.06 mm(2)/s) were significantly (P<.001) lower than in the peripheral of central zone of AC. Using the statistical analysis (Akaike information criteria) in YV most pixels were best described by the biexponential model (82%), the statistical model, respectively kurtosis (93%) each compared to the monoexponential model. In PC the majority of pixels was best described by the monoexponential model (57%) compared to the biexponential model. CONCLUSION: Although a more complex model might provide a better fitting when multiple b-values are used, the monoexponential analyses for ADC calculation in prostate MRI is sufficient to discriminate prostate cancer from normal tissue using b-values ranging from 0 to 800 s/mm(2).

Assessment of early cartilage degeneration after slipped capital femoral epiphysis using T2 and T2* mapping.

BACKGROUND: T2 and T2* mapping are novel tools to assess cartilage quality. PURPOSE: To evaluate hip cartilage quality in the long-term follow-up of patients with slipped capital femoral epiphysis (SCFE) with T2 and T2* mapping. MATERIAL AND METHODS: Thirty-three patients (19 men, 14 women, mean age 24 ± 6.0 years, range 18-51 years) with a history of SCFE in 41 hips and 10 healthy controls (seven men, mean age 22 ± 4 years) were included. Follow-up period was 12 ± 6 (range 4-39 years) years. Coronal T2 and T2* mapping were performed on a 1.5 T scanner. T2 and T2* values of the hip articular cartilage were determined in the medial, central, and lateral portion of the hip within the weight bearing zone. Clinical symptoms including pain were assessed with the Harris hip score. Statistical analysis was performed using Mann-Whitney U test and Spearman rank sum test. RESULTS: In hips after SCFE T2 (central portion: 25.71 ms ± 4.84 ms vs. 29.71 ms ± 7.04 ms, p<0.05) and T2* (central portion: 20.76 ms ± 3.17 ms vs. 23.06 ms ± 2.68 ms, P<0.01) of cartilage were significantly lower, compared to controls. The differences were most apparent in the lateral portion of the hip articular cartilage. Abnormal cartilage T2 and T2* were not associated with hip pain or impaired hip function. SCFE was unilateral in 23 cases (70%). In the patients' unaffected hips without SCFE, areas of significantly reduced T2 (central portion: 26.07 ms ± 4.27 ms, P<0.05) and T2* (lateral portion: 23.23 ms ± 2.45 vs. 25.11 ms ± 3.01 ms, P<0.05) were noted. CONCLUSION: T2 and T2* mapping of the hip in patients after SCFE are significantly different from healthy controls and may offer additional information about cartilage quality.